Examining Protein Domains For Targeted Biologic Drug Delivery

FEBRUARY 2023

The End of Alopecia?

NOVEMBER 2022

BiologicsMD: The Model Of A Well-Funded Biotech Startup

NOVEMBER 2022

Dr. Brett King Joins BiologicsMD as Senior Scientific Advisor and Member of the Scientific Advisory Board

OCTOBER 2022

SmartTRAK: BiologicsMD: Targeted Treatments for Bone Disorders and Hair Loss

AUGUST 2022

Scrip: BiologicsMD Uses Unique Fusion Proteins To Treat Alopecia Safely

JUNE 2022

Follicle Thought: BiologicsMD Announces Patent for Hair Growth Protein

JANUARY 2016

BiologicsMD, Inc. Announces Additional US Patent Issuance Covering Company’s Pipeline of Targeted Therapies

JULY 2015

BiologicsMD, Inc. Announces Issuance of Patent for PTH-CBD™ in Japan

AUGUST 2014

BiologicsMD, Inc. Announces Issuance of First U.S. Patent for PTH-CBD™

AUGUST 2013

BiologicsMD, Inc. Announces the Appointment of J. David Owens as Chief Executive Officer

JULY 2013

BiologicsMD, Inc. Awards Manufacturing Contract to Cytovance Biologics, Inc. to Expand Development of Breakthrough Osteoporosis Medication

JUNE 2012

BiologicsMD Selected for $2.3 Million Department of Defense Contract

FEBRUARY 2011

Arkansas Business: Winning BiologicsMD Team Rides Venture Capital Whirlwind

JUNE 2010